2025 -  WEEK 26

What's New in RWE Research this Week

  1. A Real-World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms. Stocchi F, Kulisevsky J, Jost WH.Mov Disord Clin Pract. 2025 Jun 23. doi: 10.1002/mdc3.70188. Online ahead of print.PMID: 40545913

 

  1. Adverse Effects Related to SARS-CoV-2 Vaccination in Patients With Rheumatic Diseases and Psoriasis From Argentina. Isnardi CA, Pisoni C, Cosatti M, Roberts K, Virasoro BM, Kreimer J, Echeverría C, D'Angelo ME, Pereira D, Petkovic I, Tissera YS, Correa MÁ, Rodríguez Gil G, Quintana R, Cogo K, Alonso C, Kogan N, Toledo AL, Alfaro MA, Nieto R, García L, Rollano Perasso A, Debernardi ME, Troyano Z, Strusberg I, Pons-Estel GJ, Schneeberger EE.J Clin Rheumatol. 2025 Jun 23. doi: 10.1097/RHU.0000000000002251. Online ahead of print.PMID: 40548899

 

  1. Correction: Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. Yoshinami T, Takano Y, Ozaki Y, Kajiwara Y, Yamamoto M, Watanabe KI, Tsukabe M, Fujisawa F, Nagai SE, Shibata N, Oshiro C, Bando H, Tsunoda N, Yamagami K, Koizumi K, Takada M, Toriguchi N, Sekine N, Kawaguchi T, Saji S, Sagara Y, Morita S, Masuda N.Breast Cancer. 2025 Jun 23. doi: 10.1007/s12282-025-01736-0. Online ahead of print.PMID: 40549070 No abstract available.

 

  1. Bayesian dynamic power prior borrowing for augmenting a control arm for survival analysis. Wang J, Sengupta S, Tiwari R. J Biopharm Stat. 2025 Jun 26:1-22. doi: 10.1080/10543406.2025.2519153. Online ahead of print. PMID: 40568794

 

  1. Key Considerations for Assessing Real-World Comparative Effectiveness in the Context of the Drug Price Negotiation Program: A Case Study of Pembrolizumab. Zemplenyi AT, Chen NC, Anderson KE, Adamson B, DiStefano MJ, Nair KV, McQueen RB. 2025 Jun 23. doi: 10.1007/s40273-025-01514-y. Online ahead of print.PMID: 40549122

 

  1. Epidemiology and Steroid Dependency Reduction in Crohn's Disease During the Biologics Era: A Nationwide Population-Based Study. Chen NY, Chuang CH, Chang YC, Kao Yang YH, Hsu H, Chen CM, Cheng CL.Adv Ther. 2025 Jun 23. doi: 10.1007/s12325-025-03245-0. Online ahead of print.PMID: 40549269

 

  1. A population-based cohort to evaluate drug safety during pregnancy (PREGVAL): rationale, design, and baseline characteristics. Sánchez-Sáez F, Sanfélix-Gimeno G, Hurtado I, García-Sempere A, Garcés-Sánchez M, Llopis-Cardona F, Peiró S, Rodríguez-Bernal CL.Eur J Epidemiol. 2025 Jun 23. doi: 10.1007/s10654-025-01260-7. Online ahead of print.PMID: 40549278

 

  1. Cohort profile: the Guangzhou older longitudinal dynamic health (GOLD-Health) cohort. Liu H, Wang X, Lin W, Chen G, Chen J, Zhang Z, Zhou Q, Yang Y, Liu X, Zhang J, Fang Y, Luo L, Lin H, Zhang Z.Eur J Epidemiol. 2025 Jun 23. doi: 10.1007/s10654-025-01254-5. Online ahead of print.PMID: 40549279

 

  1. Trends in Myocardial Infarction risk by HIV status in two U.S. healthcare systems. Lea AN, Lyass A, Hurley LB, Ehrbar RQ, Mahoney TF, Borowsky LH, He W, Plutzky J, Triant VA, Silverberg MJ.PLoS One. 2025 Jun 23;20(6):e0325773. doi: 10.1371/journal.pone.0325773. eCollection 2025.PMID: 40549744 Free PMC article.

 

  1. Using large-scale population-based data to improve disease risk assessment of clinical variants. Forrest IS, Huang KL, Eggington JM, Chung WK, Jordan DM, Do R.Nat Genet. 2025 Jun 23. doi: 10.1038/s41588-025-02212-3. Online ahead of print.PMID: 40551016 Review.

 

  1. Α 6-month, multicenter, observational study investigating the treatment of venous thromboembolism in Greece (VICTORIA study). Savvari P, Skiadas I, Mavrokefalou E, Kakkos S, Antoniou I, Pitoulias GA, Dima E, Ferdoutsis E, Ntaios G, Giannoukas A, Kotsiou O, Zagouri F, Tsoukalas G, Kostikas K, Staramos D, Milionis H, Filis K, Savopoulos C, Kakisis I, Tzilalis V, Koulouris N, Papas T, Skrapari I, Menegas D; VICTORIA Study Group.Thromb J. 2025 Jun 23;23(1):71. doi: 10.1186/s12959-025-00749-1.PMID: 40551211 Free PMC article.

 

  1. Rethinking research in urology: pitfalls from the Talent Incubator Programme. Cerrato C, Vásquez JL; European Association of Urology Young Urologist Office (EAU‐YOU).BJU Int. 2025 Jun 23. doi: 10.1111/bju.16837. Online ahead of print.PMID: 40551493 No abstract available.

 

  1. Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints. Hutson AD, Yu H.Stat Methods Med Res. 2025 Jun 23:9622802251343599. doi: 10.1177/09622802251343599. Online ahead of print.PMID: 40551565

 

  1. Severe Paediatric Asthma Collaborative in Europe: real-world data on children on biologics. Liu NM, Pijnenburg MW, Deschildre A, de Mir-Messa I, Adalen S, Amat F, Antonino L, Biermé P, Bravo-Lopez M, Carlsen KCL, Carraro S, Cros P, Delestrain C, Diaz Garcia C, Epaud R, Fenu G, Ferraro VA, Fleming L, Hanssens L, Heine A, Labouret G, Leoni MC, Licari A, Lombardi E, Lopez Neyra A, Marguet C, Mazenq J, Pérez Tarazona S, Díaz JCR, Schweitzer C, Spada E, Valverde Molina J, Verhulst S, Wanin S, Rusconi F.ERJ Open Res. 2025 Jun 23;11(3):00709-2024. doi: 10.1183/23120541.00709-2024. eCollection 2025 May.PMID: 40551791 Free PMC article.

 

  1. Real-world evidence on biologic use in paediatric asthma: there but not there yet? Chen W.ERJ Open Res. 2025 Jun 23;11(3):00209-2025. doi: 10.1183/23120541.00209-2025. eCollection 2025 May.PMID: 40551792 Free PMC article.

 

  1. Epidemiology and patient characteristics of the US myasthenia gravis population: real-world evidence from a large insurance claims database. Miller-Wilson LA, Arackal J, Edwards Y, Schwinn J, Rockstein KE, Venker B, Nowak RJ.BMJ Neurol Open. 2025 Jun 23;7(1):e001076. doi: 10.1136/bmjno-2025-001076. eCollection 2025.PMID: 40556711 Free PMC article.

 

  1. Mortality, kidney, and safety outcomes with SGLT2 inhibitors versus DPP4 inhibitors in patients with type 2 diabetes treated with systemic glucocorticoids: a real-world exploratory study. Schechter M, Cohen Y, Fishkin A, Mosenzon O, Leibowitz G, Aharon-Hananel G.Diabetes Res Clin Pract. 2025 Jun 23:112338. doi: 10.1016/j.diabres.2025.112338. Online ahead of print.PMID: 40562217

 

  1. Real-World Treatment Patterns and Out-of-Pocket Costs After CAR T-Cell Therapy in Commercially Insured Patients with B-Cell Non-Hodgkin Lymphoma in the United States. Zuber M, Elshafie S, Taj S, Zapata LV.Transplant Cell Ther. 2025 Jun 23:S2666-6367(25)01261-8. doi: 10.1016/j.jtct.2025.06.018. Online ahead of print.PMID: 40562233

 

  1. Venous Thromboembolism Outcomes by Geographic Region and Self-Reported Race: Insights from the RIETE Registry. Tafur AJ, Brenner B, Demelo-Rodríguez P, Guirado L, Pedrajas JM, Mazzolai L, Montenegro AC, Tirado R, Villalobos A, Monreal M; RIETE Investigators.Thromb Haemost. 2025 Jun 24. doi: 10.1055/a-2615-4591. Online ahead of print.PMID: 40389232

 

  1. Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use. Megna M, Lauletta G, D'Agostino M, Tommasino N, Salsano A, Noto M, Brescia C, Foggia L, Scaramuzzino L, Potestio L.Expert Opin Biol Ther. 2025 Jun 24:1-19. doi: 10.1080/14712598.2025.2519525. Online ahead of print.PMID: 40522209 Review.

 

  1. Social influence during public crises: Weekly dynamics and adaptive patterns of conformity to the collective following the COVID-19 outbreak. Ge X, Hou Y.Proc Natl Acad Sci U S A. 2025 Jun 24;122(25):e2500008122. doi: 10.1073/pnas.2500008122. Epub 2025 Jun 18.PMID: 40531868

 

  1. The incidence of severe complications in liver donation from living donors: Real-world data in the era of minimally invasive surgery. Haruki K, Krishnamurthy J, Kumar Olaniya M, Shankar S, Rammohan A, Rhu J, Yilmaz TU, Toshima T, Waisberg DR, Andraus W, Lee J, Okumura S, Gopal P, Hara T, Sakurai Y, Takahashi R, Zamora-Valdes D, Yang Z, Minnee RC, Rela M, Gupta S, Ikegami T, Lee KW.Liver Transpl. 2025 Jun 24. doi: 10.1097/LVT.0000000000000660. Online ahead of print.PMID: 40548878

 

  1. Big data and cardiovascular risk-insights into obesity, diabetes, and coronary heart disease. Dörr M. 2025 Jun 24. doi: 10.1007/s00059-025-05323-z. Online ahead of print.PMID: 40553126 Review. English.

 

  1. Efficacy and safety of using Elexacaftor/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil. Martins GDS, Rambo C, Spessatto G, Saab MM, João BHD, Fajardo AD, Primon JG, Picciani TG, da Cunha RC, Chong-Neto HJ, Massignan CRL, Silva-Filho LVRFD, Riedi CA, Filho NAR, Chong-Silva DC.J Pediatr (Rio J). 2025 Jun 24:S0021-7557(25)00098-1. doi: 10.1016/j.jped.2025.05.007. Online ahead of print.PMID: 40553696 Free article.

 

  1. Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. John S, Curran KJ, Hall EM, Keating A, Baumeister SHC, Nikiforow S, Driscoll T, Moskop A, McNerney KO, Phillips CL, Pulsipher MA, Hsieh EM, Rouce RH, Pasquini MC, Tiwari R, Willert J, Ramos RJ, Krueger J, Guest E, Grupp SA.Blood Adv. 2025 Jun 24:bloodadvances.2025015881. doi: 10.1182/bloodadvances.2025015881. Online ahead of print.PMID: 40554426

 

  1. Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population. Relan S, Alarcon G, Guffey D, Minard CG, Fang ME, Timmons K, Sonabend RY, Tosur M, Redondo MJ, Posey JE.J Clin Endocrinol Metab. 2025 Jun 24:dgaf360. doi: 10.1210/clinem/dgaf360. Online ahead of print.PMID: 40554608

 

  1. Risk factors for development of diabetic foot ulcer disease in two large contemporary UK cohorts. Gharibzadeh S, Lee J, Highton P, Greenlaw N, Gillies C, Zaccardi F, Brennan A, Pollard DJ, Valabhji J, Game F, Stanley B, Leese G, Gray L, Tesfaye S, Webb D, Wild S, Shabnam S, Davies M, Khunti K, Petrie J, Gregg E.Diabetes Obes Metab. 2025 Jun 24. doi: 10.1111/dom.16519. Online ahead of print.PMID: 40555701

 

  1. PIONEER REAL Spain: A multicentre, prospective, real-world study of oral semaglutide use in adults with type 2 diabetes. Delgado Álvarez E, Morales Portillo C, Abreu Padín C, Aliaga Verdugo A, Piera Carbonell A, Cadenas González A, Amor Valero J, González López V, Rasmussen CL, Scheuer SH, Bellido Guerrero D.Diabetes Obes Metab. 2025 Jun 24. doi: 10.1111/dom.16523. Online ahead of print.PMID: 40555703

 

  1. A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database. Fang C, Xu X, Li J, Zhong Y, Dai W, Wen J, Yang Q, Chen R.Sci Rep. 2025 Jun 24;15(1):20272. doi: 10.1038/s41598-025-05680-z.PMID: 40555731 Free PMC article.

 

  1. Treatment trends and outcomes of pyogenic vertebral osteomyelitis in Japan, 2015-2023: A descriptive epidemiological study. Yoshiyama T, Fukasawa T, Masuda S, Otsuki B, Murata K, Shimizu T, Sono T, Honda S, Shima K, Sakamoto M, Saito R, Matsuda S, Kawakami K.J Orthop Sci. 2025 Jun 24:S0949-2658(25)00184-8. doi: 10.1016/j.jos.2025.06.003. Online ahead of print.PMID: 40562610

 

  1. Pattern of semaglutide prescription in a real-world Canadian patient cohort. Farahvash A, Lee MC, Jain R, Jaakkimainen L.Prim Care Diabetes. 2025 Jun 24:S1751-9918(25)00115-9. doi: 10.1016/j.pcd.2025.06.006. Online ahead of print.PMID: 40562647

 

  1. Real-World Effectiveness and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients with Phe508del -Gating and -Residual Function Genotypes. Salvatore D, Iacotucci P, Pepe A, Terminiello A, Majo F, Carnovale V, Vitullo P, Messore B, Parisi GF, Calderazzo MA, Leonetti G, Terlizzi V.Respir Med. 2025 Jun 24:108221. doi: 10.1016/j.rmed.2025.108221. Online ahead of print.PMID: 40571167

 

  1. Comparative effectiveness and safety of biosimilars versus reference biologics in rheumatoid arthritis during treatment initiation: a systematic review of real-world evidence. Yiu CH, Yau GTY, Wong ZH, Lin CY, Day RO, Raubenheimer J, Lu CY.Int J Clin Pharm. 2025 Jun 25. doi: 10.1007/s11096-025-01956-6. Online ahead of print.PMID: 40560336 Review.

 

  1. How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical®Hybrid Cannabis Extract. Wagner Y, Samel I, Probst K, Schollenberger L, Ruckes C, Nadstawek J; ESCAPE Study Group.Adv Ther. 2025 Jun 25. doi: 10.1007/s12325-025-03262-z. Online ahead of print.PMID: 40560527

 

  1. Raising Awareness: Real World Data On Palliative Care for Advanced Pediatric Cancers in Bavaria. Nehls N, Börner M, Ziegelmayer S, Haller B, Klot FF, Metzler M, Frühwald MC, Schlegel PG, Corbacioglu S, Feuchtinger T, Lüttichau IT.Pediatr Blood Cancer. 2025 Jun 25:e31870. doi: 10.1002/pbc.31870. Online ahead of print.PMID: 40563219

 

  1. Temporal dynamics in laboratory medicine: cosinor analysis and real-world data (RWD) approaches to population chronobiology. Marques-Garcia F, Martinez-Bravo C, Tejedor-Ganduxe X, Fossion R.Clin Chem Lab Med. 2025 Feb 19;63(7):1392-1401. doi: 10.1515/cclm-2024-1198. Print 2025 Jun 26.PMID: 39963961

 

  1. Treatment patterns and blood count control in 10,112 patients with polycythemia vera. Pemmaraju N, Yu J, Vasudevan A, Qureshi H, Braunstein E, Chojecki A.Expert Rev Hematol. 2025 Jun 26:1-8. doi: 10.1080/17474086.2025.2520316. Online ahead of print.PMID: 40512071

 

  1. The Effectiveness of Regular Opioids for Dyspnea Among Opioid-Tolerant Patients with Cancer: A Comparison of Increasing Baseline Opioids Versus Opioid Switch/Combination Therapy. Suzuki K, Matsuda Y, Mori M, Tasaki J, Matsunuma R, Ikari T, Miwa S, Aiki S, Takagi Y, Kiuchi D, Oyamada S, Ariyoshi K, Kihara K, Yamaguchi T.J Palliat Med. 2025 Jun 26. doi: 10.1089/jpm.2024.0487. Online ahead of print.PMID: 40566948

 

  1. Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice. Frustaci AM, Galitzia A, Lucignano M, Appio L, Olivieri J, Sanna A, Baraté C, Pane F, Schiattone L, Casadei B, Ferrarini I, Figuera A, Sportoletti P, Loseto G, Stelitano C, Visentin A, Celli M, Mauro FR, Palombi M, Coscia M, Innao V, Moia R, Motta M, Russo F, Tani M, Arcari A, Boccellato E, Borella C, Capochiani E, Ferrari A, Gentile M, Giachetti R, Giordano A, Bullo M, Lista E, Malandruccolo L, Musso M, Varettoni M, Vozella F, Cibien F, Merli M, Nocilli L, Pasquini MC, Romeo AA, Rossi V, Turri G, Vanazzi A, Cavaliere M, Gozzetti A, Crucitti L, Lucesole M, Deodato M, Tomasso A, Zappaterra A, Murru R, Patti C, Laurenti L, Tedeschi A. 2025 Jun 26. doi: 10.3324/haematol.2025.287799. Online ahead of print.PMID: 40568727 Free article.

 

  1. Bayesian dynamic power prior borrowing for augmenting a control arm for survival analysis. Wang J, Sengupta S, Tiwari R.J Biopharm Stat. 2025 Jun 26:1-22. doi: 10.1080/10543406.2025.2519153. Online ahead of print.PMID: 40568794

 

  1. A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer. Lloyd MR, Chica-Parrado R, Weipert CM, Knepper TC, Podany EL, Napolitano F, Ye D, Lin CC, Uemoto Y, Liao J, Wegrzyn C, Walko CM, Ryan LY, Keenan JC, Medford AJ, Liu SA, Wulf GM, Clifton KK, Ma CX, Han HS, Zhang N, Ellisen LW, Bardia A, Arteaga CL, Hanker AB, Wander SA. 2025 Jun 26;118:105828. doi: 10.1016/j.ebiom.2025.105828. Online ahead of print.PMID: 40578027

 

  1. Potential protective advantage of the protein-subunit SARS-CoV-2 vaccines, MVC-CoV1901 and NVX-CoV2373, in patients with rituximab-treated immune-mediated inflammatory diseases: Real-world evidence. Lai PH, Lan TY, Lu CH, Hsieh SC.J Formos Med Assoc. 2025 Jun 26:S0929-6646(25)00320-1. doi: 10.1016/j.jfma.2025.06.029. Online ahead of print.PMID: 40579271

 

  1. Radium-223 in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Literature Review of Real-world Outcomes in Observational Studies. Lunan-Taylor M, Raval AD, Nhan Phan NT, Korn MJ, Quintero V, McKay RR.Eur Urol Oncol. 2025 Jun 26:S2588-9311(25)00172-5. doi: 10.1016/j.euo.2025.06.002. Online ahead of print.PMID: 40579287 Review.

 

  1. Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study. Giannini EG, Pasta A, Bucci L, Plaz Torres MC, Pieri G, Celsa C, Sangiovanni A, Piscaglia F, Campani C, Missale G, Vidili G, Ghittoni G, Pelizzaro F, Foschi FG, Morisco F, Santi V, Svegliati-Baroni G, Azzaroli F, Saitta C, Brunetto MR, Sacco R, Ponziani FR, Boninsegna S, Nardone G, Martini A, Mega A, Sacerdoti D, Magalotti D, Vitale A, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group.Dig Liver Dis. 2025 Jun 26:S1590-8658(25)00805-9. doi: 10.1016/j.dld.2025.05.032. Online ahead of print.PMID: 40579332

 

  1. Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in France. Yang J, Tamberou C, Arnee E, Squara PA, Boukhlal A, Nguyen JL, Volkman HR, Fievez S, Lepoutre-Bourguet M, Ben Romdhane H, Renaudat C, Crépey P, Robineau O.J Med Econ. 2025 Jun 27:1-17. doi: 10.1080/13696998.2025.2525002. Online ahead of print.PMID: 40574623

 

  1. The Impact of Smoking on Nivolumab Outcomes in Renal Cell Carcinoma: Real-World Data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC). Sertesen Camoz E, Bolek H, Kuzu OF, Sim S, Karakaş H, Sekmek S, Guliyev M, Akkus AF, Isık S, Tural D, Arslan C, Goksu SS, Sever ON, Karadurmuş N, Karacin C, Ozguroglu M, Sendur MAN, Yekedüz E, Ürün Y. 2025 Jun 27:oyaf186. doi: 10.1093/oncolo/oyaf186. Online ahead of print.PMID: 40577354

 

  1. Treatment and Disease Burden in a Cohort of People With Haemophilia Without Inhibitors in the United States. Wheeler AP, Cibelli E, Hanson G, Percier C, Porstmann T, Shridhar N, Shapiro A. 2025 Jun 27:e70078. doi: 10.1111/hae.70078. Online ahead of print.PMID: 40577405

 

  1. Integrating Next-Generation Sequencing Into Routine Molecular Diagnosis of Inherited Coagulation Factor Deficiencies: Real-World Data From Spanish Patients. Borràs N, Comes N, Ramírez L, Parra R, Altisent C, Lorenzo-Vizcaya Á, Marzo-Alonso C, López-Fernández MF, Canaro M, Falcón-Rodríguez M, Cortes-Vidal Á, Rios de Paz MA, Rodríguez-García JA, Moreto-Quintana A, Bandini P, Hobeich C, Corrales I, Vidal F. 2025 Jun 27:e70075. doi: 10.1111/hae.70075. Online ahead of print.PMID: 40577417

 

  1. Predictors of treatment response and overall survival in patients with breast cancer brain metastases treated with stereotactic radiosurgery: a prospective study using the NeuroPoint Alliance SRS Registry. Katsos K, Michalopoulos G, D'Ambrosio AL, Cobb WS, Grills IS, McInerney J, Jensen RL, Chang E, Andrews DW, Pouratian N, Timmerman R, Attia A, Spalding AC, Walter K, Bydon M, Asher AL, Sheehan JP.J Neurosurg. 2025 Jun 27:1-12. doi: 10.3171/2025.3.JNS241471. Online ahead of print.PMID: 40577855

 

  1. Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real-Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy. Caldarola G, Dattola A, Bernardini N, Blundo V, Campione E, De Luca E, Giordano D, Giunta A, Moretta G, Orsini D, Pagnanelli G, Richetta A, Picchianti Diamanti A.Int J Dermatol. 2025 Jun 27. doi: 10.1111/ijd.17927. Online ahead of print.PMID: 40579388

 

  1. Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study. Kleppinger C, Ivy D, Stockbridge N, Bates A, Handler S, Krishnan US, Mullen MP, Yung D, Hopper RK, Varghese NP, Fineman J, Austin ED, Avitabile CM, Freire G, Clark J, Sun H.AAPS J. 2025 Jun 27;27(5):114. doi: 10.1208/s12248-025-01098-7.PMID: 40579609

 

  1. Burden of chronic spontaneous urticaria relative to atopic dermatitis and psoriasis in the United States. Soong W, Patil D, Rodrigues J, Kohli RK, Krupsky K, Gupta S, Balkaran BL, Balp MM.J Dermatolog Treat. 2025 Dec;36(1):2517384. doi: 10.1080/09546634.2025.2517384. Epub 2025 Jun 24.PMID: 40556432 Free article.